Bioline Rx Ltd Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| CITADEL ADVISORS LLC | 02/17/2026 | 36.65 K | $104.46 K | 265.78% | 0.89% |
| CITADEL ADVISORS LLC | 02/17/2026 | 12.00 K | $34.20 K | 100.00% | 0.29% |
| CITADEL ADVISORS LLC | 02/17/2026 | 11.60 K | $33.06 K | 100.00% | 0.28% |
| RHUMBLINE ADVISERS | 02/13/2026 | 3.35 K | $9.55 K | 9.22% | 0.08% |
| CITIGROUP INC | 02/13/2026 | 2.04 K | $5.81 K | 100.00% | 0.05% |
| UBS GROUP AG | 01/29/2026 | 1.95 K | $5.40 K | -69.45% | 0.05% |
| WELLS FARGO & COMPANY/MN | 02/13/2026 | 1.75 K | $4.85 K | 0.00% | 0.04% |
| BNP PARIBAS ARBITRAGE, SNC | 02/10/2026 | 1.50 K | $4.16 K | 100.00% | 0.04% |
| NEMES RUSH GROUP LLC | 02/11/2026 | 250 | $693 | 0.00% | 0.01% |
| NEWEDGE ADVISORS, LLC | 02/18/2026 | 107 | $296 | 0.00% | 0.00% |
| MORGAN STANLEY | 02/13/2026 | 100 | $277 | -98.32% | 0.00% |
| ADVISOR GROUP HOLDINGS, INC. | 02/17/2026 | 26 | $71 | 2,500.00% | 0.00% |
| ROCKEFELLER CAPITAL MANAGEMENT L.P. | 03/17/2026 | 12 | $33 | 0.00% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 02/17/2026 | 10 | $28 | 400.00% | 0.00% |
| DANSKE BANK A/S | 02/02/2026 | 2 | $6 | 0.00% | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 0 | $0 | -100.00% | 0.00% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 02/17/2026 | 0 | $0 | -100.00% | 0.00% |
| SBI SECURITIES CO., LTD. | 02/03/2026 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Bioline Rx Ltd institutional Ownership - FAQ's
During the previous two years, 20 institutional investors and hedge funds held shares of Bioline Rx Ltd. The most heavily invested institutionals were:
RHUMBLINE ADVISERS: 2,353
BNP PARIBAS ARBITRAGE, SNC: 1,800
WELLS FARGO & COMPANY/MN: 1,750
CITIGROUP INC: 1,728
UBS Group AG: 529
Nemes Rush Group LLC: 250
1.16% of Bioline Rx Ltd stock is owned by institutional investors.
Institutional investors have bought a total of 876.17 K shares in the last 24 months. This purchase volume represents approximately $2.32 M in transactions.